Successful treatment of acute liver failure due to Wilson's disease: Serendipity or fortuity?

IF 2.5 Q2 GASTROENTEROLOGY & HEPATOLOGY
Valeria Delle Cave, Fabiola Di Dato, Pier Luigi Calvo, Maria Immacolata Spagnuolo, Raffaele Iorio
{"title":"Successful treatment of acute liver failure due to Wilson's disease: Serendipity or fortuity?","authors":"Valeria Delle Cave, Fabiola Di Dato, Pier Luigi Calvo, Maria Immacolata Spagnuolo, Raffaele Iorio","doi":"10.4254/wjh.v16.i8.1111","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute liver failure (ALF) may be the first and most dramatic presentation of Wilson's disease (WD). ALF due to WD (WD-ALF) is difficult to distinguish from other causes of liver disease and is a clear indication for liver transplantation. There is no firm recommendation on specific and supportive medical treatment for this condition.</p><p><strong>Aim: </strong>To critically evaluate the diagnostic and therapeutic management of WD-ALF patients in order to improve their survival with native liver.</p><p><strong>Methods: </strong>A retrospective analysis of patients with WD-ALF was conducted in two pediatric liver units from 2018 to 2023.</p><p><strong>Results: </strong>During the study period, 16 children (9 males) received a diagnosis of WD and 2 of them presented with ALF. The first was successfully treated with an unconventional combination of low doses of D-penicillamine and zinc plus steroids, and survived without liver transplant. The second, exclusively treated with supportive therapy, needed a hepatotransplant to overcome ALF.</p><p><strong>Conclusion: </strong>Successful treatment of 1 WD-ALF patient with low-dose D-penicillamine and zinc plus steroids may provide new perspectives for management of this condition, which is currently only treated with liver transplantation.</p>","PeriodicalId":23687,"journal":{"name":"World Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362907/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4254/wjh.v16.i8.1111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute liver failure (ALF) may be the first and most dramatic presentation of Wilson's disease (WD). ALF due to WD (WD-ALF) is difficult to distinguish from other causes of liver disease and is a clear indication for liver transplantation. There is no firm recommendation on specific and supportive medical treatment for this condition.

Aim: To critically evaluate the diagnostic and therapeutic management of WD-ALF patients in order to improve their survival with native liver.

Methods: A retrospective analysis of patients with WD-ALF was conducted in two pediatric liver units from 2018 to 2023.

Results: During the study period, 16 children (9 males) received a diagnosis of WD and 2 of them presented with ALF. The first was successfully treated with an unconventional combination of low doses of D-penicillamine and zinc plus steroids, and survived without liver transplant. The second, exclusively treated with supportive therapy, needed a hepatotransplant to overcome ALF.

Conclusion: Successful treatment of 1 WD-ALF patient with low-dose D-penicillamine and zinc plus steroids may provide new perspectives for management of this condition, which is currently only treated with liver transplantation.

成功治疗威尔逊氏病导致的急性肝衰竭:偶然还是巧合?
背景:急性肝衰竭(ALF)可能是威尔逊氏病(WD)的首发症状,也是最显著的表现。WD引起的ALF(WD-ALF)很难与其他原因引起的肝病区分开来,是肝移植的明确指征。目的:对WD-ALF患者的诊断和治疗方法进行严格评估,以提高他们的原肝存活率:对2018年至2023年两个儿科肝病科的WD-ALF患者进行回顾性分析:在研究期间,16名儿童(9名男性)被诊断为WD,其中2名出现ALF。第一名患儿接受了小剂量D-青霉胺和锌加类固醇的非常规联合治疗,并成功存活,未进行肝移植。第二例患者只接受了支持疗法,需要进行肝移植才能克服 ALF:结论:用小剂量D-青霉胺和锌加类固醇成功治疗了一名WD-ALF患者,这为治疗这种目前只能通过肝移植治疗的疾病提供了新的视角。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Hepatology
World Journal of Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.10
自引率
4.20%
发文量
172
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信